DeutschNewstral
Article
bizjournals.com on 2022-04-05 18:14
Gene therapy developer bluebird bio to cut 30% of staff
Related news
- BBluebird Bio Suspends Gene Therapy Trials, Marketing After Cancer Diagnosisbarrons.com
- FBluebird Bio prices gene therapy at nearly $1.8mft.com
- Cambridge gene therapy firm bluebird bio to move to Somervillebizjournals.com
- Spark Therapeutics sues gene therapy rival Bluebird Biobizjournals.com
- Bluebird bio sued by gene therapy rival Spark Therapeuticsbizjournals.com
- Gene therapy firm bluebird bio to split into two companiesbizjournals.com
- Chicago biotech sues Third Rock, bluebird bio CEO over gene therapy licensebizjournals.com
- Gene therapy firm Bluebird Bio, with Durham site, to split into two companiesbizjournals.com
- News out of bluebird bio could delay IPOs for two local gene therapy firmsbizjournals.com
- BGene-Therapy Firm Bluebird Bio Is Spinning Off Its Cancer Programsbarrons.com
Bluebird Bio Sickle-Cell Therapy Helped Teenwsj.com- GGene Therapy Products Market Top Company, Geographical Region, and Industry Segments till 2027| Bluebird Bio, Sangamo, Spark Therapeuticsgalleonnews.com
- Gene therapy developer Passage Bio adds a trio to its C-suitebizjournals.com
- International gene therapy developer Exegenesis opens U.S. offices in Montco, plans to triple local staffbizjournals.com
- BBluebird Says Gene-Therapy Patient's Cancer Seems Not Treatment-Relatedbarrons.com
- KGlobal Gene Therapy Products Market 2020-2026 Study & Future Prospects Including key players Anchiano Therapeutics, bluebird bio, Inc., CELGENE CORPORATION, GlaxoSmithKline plcksusentinel.com
- Gene therapy developer Gyroscope Technologies raises $60.6Mbizjournals.com
- LGene Therapy Market Size, Forecast to 2028 | Key Manufacturers – Novartis AG, Biogen, Gilead Sciences MolMed S.p.A., Spark Therapeutics Orchard Therapeutics plc., SIBIONO, Bluebird bio Shanghai Sunway Biotech Co. Ltd.liverpoolstudentmedia.com
- BWall Street Looks Again at Bluebird, Rivals, After Gene-Therapy Setbackbarrons.com
- BHow a Cloud Is Lifting from Bluebird and Other Gene Therapy Stocksbarrons.com